Загрузка...
Growth inhibitory effect of the Src inhibitor dasatinib in combination with anticancer agents on uterine cervical adenocarcinoma cells
Uterine cervical adenocarcinoma has a poor clinical prognosis when compared with squamous cell carcinoma. Therefore, the development of new treatment strategies for uterine cervical adenocarcinoma is necessary. Src is a proto-oncogene that is important in cancer progression. Dasatinib is a Src inhib...
Сохранить в:
| Опубликовано в: : | Exp Ther Med |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
D.A. Spandidos
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5647549/ https://ncbi.nlm.nih.gov/pubmed/29067110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2017.5061 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|